AbbVie (ABBV) Tops Q2 EPS by 6c, Revenue Beats, Updates FY Guidance
Tweet Send to a Friend
AbbVie (NYSE: ABBV) reported Q2 EPS of $2.26, $0.06 better than the analyst estimate of $2.20. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
